legislation: 117-s-6
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117-s-6 | 117 | s | 6 | Biosimilar Red Tape Elimination Act | Health | 2022-11-17 | 2022-11-17 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | Senate | Sen. Lee, Mike [R-UT] | UT | R | L000577 | 0 | Biosimilar Red Tape Elimination Act This bill removes and otherwise modifies certain requirements related to the approval of biosimilars, such as prohibiting the Food and Drug Administration from requiring studies that assess the risks of switching between the biosimilar and the reference biologic. | 2023-08-15T19:45:20Z |